Skip to main content
TipRanks
Go Ultimate75% OFF

DMCC Speciality Chemicals Limited (DMCC) AI Stock Analysis

0 Followers
IN:DMCC

DMCC Speciality Chemicals Limited

(NSE:DMCC)

Select Model
Rating:47Neutral
Price Target:INR 250.00â–²(0.93% Upside)
Action:reiterated
Date:10/31/26

The overall score is heavily pressured by extremely weak technicals and deteriorating financial performance. The stock is in a clear downtrend with bearish momentum, while negative operating cash flow and collapsing margins raise fundamental concerns. A reasonable P/E ratio provides some support, but it is insufficient to offset the dominant risks in financial health and price trend.

Positive Factors
Manageable LeverageDebt-to-equity around 0.35 in FY2026 and steadily expanding equity indicate manageable leverage and a stronger capital base. This provides some resilience and borrowing capacity over the next several quarters, although maintaining that flexibility depends on restoring cash generation.
Negative Factors
Negative Cash GenerationOperating cash flow and free cash flow both turned negative in FY2026 after positive FY2024-FY2025 cash generation. This weak conversion of reported earnings into cash can constrain internally funded growth, increase reliance on financing, and make near-term financial execution more fragile.

DMCC Speciality Chemicals Limited (DMCC) vs. iShares MSCI India ETF (INDA)

-30%-20%-10%0%10%20%30%40%IN:DMCC-8.95%INDA-5.86%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Market Cap
INR 6.16B
Dividend Yield
1.00%
Average Volume (3M)
9,036
Price to Earnings (P/E)
16.5
Beta (1Y)
0.56
Revenue Growth
72.14%
EPS Growth
34.49%
Country
India
Employees
450
Sector
General
Sector Strength
55
Industry
Chemicals

DMCC Speciality Chemicals Limited Business Overview & Revenue Model

Company Description

DMCC Speciality Chemicals Limited, alongside its affiliated entities, operates as a manufacturer and global supplier of both specialty and commodity chemicals. Its distribution network spans both domestic Indian markets and international territories....

How the Company Makes Money

null

DMCC Speciality Chemicals Limited Financial Statement Overview

Summary

Revenue growth is strong, but gross margin collapsed to 16.1% and operating cash flow turned sharply negative. The balance sheet is stable with moderate leverage, yet the severe cash flow deterioration and margin compression indicate significant financial stress, resulting in a below-average score.

Income Statement

45Neutral

Balance Sheet

65Positive

Cash Flow

35Negative
Financial statement breakdown
BreakdownTTMMar 2026Mar 2025Mar 2024Mar 2023Mar 2022
Income Statement
Total Revenue8.54B5.82B4.31B3.26B3.85B3.25B
Gross Profit1.08B935.49M1.33B1.14B1.37B1.28B
EBITDA783.02M643.27M570.16M366.94M387.81M467.11M
Net Income374.55M273.29M215.28M115.89M69.31M213.40M
Balance Sheet
Total Assets4.95B4.46B3.80B3.77B4.01B3.84B
Cash, Cash Equivalents and Short-Term Investments49.02M44.55M51.52M70.63M33.50M29.59M
Total Debt1.08B865.32M470.70M877.11M1.01B933.99M
Total Liabilities2.30B1.97B1.53B1.68B2.03B1.90B
Stockholders Equity2.65B2.48B2.28B2.10B1.98B1.94B
Cash Flow
Free Cash Flow0-330.45M310.28M194.33M79.75M-480.71M
Operating Cash Flow0-270.57M380.41M383.74M298.81M506.56M
Investing Cash Flow0-69.76M-66.82M-100.42M-205.59M-984.14M
Financing Cash Flow0318.06M-297.83M-271.01M-99.94M461.07M

DMCC Speciality Chemicals Limited Technical Analysis

Technical Analysis SentimentNegative
Last Price247.70

Price Trends

50DMA291.10Negative
100DMA281.19Negative
200DMA263.78Negative

Market Momentum

MACD-16.57Positive
RSI37.18Neutral
STOCH50.32Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IN:DMCC, the sentiment is Negative. The current price of 247.70 is below the 20-day moving average (MA) of 270.73, below the 50-day MA of 291.10, and below the 200-day MA of 263.78, indicating a bearish trend. The MACD of -16.57 indicates Positive momentum. The RSI at 37.18 is Neutral, neither overbought nor oversold. The STOCH value of 50.32 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for IN:DMCC.

DMCC Speciality Chemicals Limited Peers Comparison

Overall Rating

UnderperformOutperform
Sector (55)

Financial Indicators

IN:DMCC against its peers
NameOverall RatingMarket CapP/E RatioROEDividend YieldRevenue GrowthEPS Growth
IN:INDOAMININ:INDOAMIN76OutperformINR 8.47B10.50―0.43%13.23%22.22%
IN:VALIANTORGIN:VALIANTORG63NeutralINR 10.58B15.45――21.32%175.87%
IN:PRIMOIN:PRIMO59NeutralINR 5.31B32.64――-2.70%-15.41%
Sector *55Neutral$6.65B3.83-15.92%6.20%10.91%7.18%
IN:DEEPAKNTRIN:DEEPAKNTR54NeutralINR 221.69B20.47―0.47%25.13%99.89%
IN:UNIENTERIN:UNIENTER51NeutralINR 6.72B34.44―3.65%-77.13%―
IN:DMCCIN:DMCC47NeutralINR 6.26B16.46―1.00%72.14%34.49%

* General Sector Average

Performance Comparison

-25%0%25%50%IN:DMCCIN:DEEPAKNTRIN:INDOAMININ:PRIMOIN:UNIENTERIN:VALIANTORGDec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
IN:DMCC and its peers over the selected period
Show on chartTickerCompany NamePriceChange% Change
IN:DMCCDMCC Speciality Chemicals Limited247.70-31.84-11.39%
IN:DEEPAKNTRDeepak Nitrite Limited1595.50-126.53-7.35%
IN:INDOAMINIndo Amines Limited117.00-14.17-10.80%
IN:PRIMOPrimo Chemicals Limited21.18-1.43-6.32%
IN:UNIENTERUniphos Enterprises Limited95.35-54.14-36.21%
IN:VALIANTORGValiant Organics Limited363.3077.4527.09%

DMCC Speciality Chemicals Limited Corporate Events

DMCC Speciality Chemicals Says Trading Surge Is Market-Driven, Affirms SEBI Compliance

Oct 7, 2026

The speciality chemicals producer DMCC Speciality Chemicals Limited, listed on NSE and BSE under the symbol DMCC and scrip code 506405, serves industrial markets and operates under India’s SEBI Listing Obligations and Disclosure Requirements regime....

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Date of analysis: Oct 31, 2026